The unstoppable truth of scientific study. This figure in 1970s, our paper on NK in 1990s and now the path to the cure by understanding the power of our immune system. I have been obsessed by this image and this book for decades -the coffee stains as I read and reread & reread!
@AfricanHub_ I believe its a treatment and not preventive. Public information and reveals its in infancy. No approvals yet. Finally it targets only a small type of cancers and not a global cure as light me intimated in the post. No sufficient info to support the claims of a vaccine
Two FDA approvals advance ctDNA MRD-guided adjuvant treatment in MIBC.
🟣On May 15, 2026, the FDA approved atezolizumab and atezolizumab + hyaluronidase-tqjs for adults with MIBC after cystectomy who have ctDNA MRD by an FDA-authorized test.
🟣The FDA also approved Signatera CDx as a companion diagnostic.
In IMvigor011:
• Median DFS: 9.9 vs 4.8 months
• HR 0.64; p=0.0047
• Median OS: 32.8 vs 21.1 months
• HR 0.59; p=0.0131
Takeaway: ctDNA MRD testing is becoming central to selecting patients for adjuvant treatment after cystectomy.
@ArielKann@cdanicas@therealmarcodoc@AndreaNecchi@DrYukselUrun@ZoeJuneAssaf@DrElizabethSC@OncoBellmunt@oncodaily@OncoDailyIO@FDA@NateraGenetics
📎 https://t.co/kg88Ds4pfw
#BladderCancer #MIBC #ctDNA #MRD #FDA #Atezolizumab #Tecentriq #Immunotherapy #Oncology
NEW ARTICLE: IVERMECTIN and MEBENDAZOLE Testimonial - 65 year old Canadian man with Colon and Rectal Cancers reports after 7 months: Cancer Free!
Canadian Cancer patients are under attack by politicians like @ABDanielleSmith, who have made "Right to Try" illegal.
But you can't let Big Pharma politicians hurt you! 🙏
So Canadian Cancer patients are taking matters into their own hands! 👏
STORY:
65 year old Canadian man with Colon (4cm tumor) and Rectal Cancers (2cm tumor)
Had 2-3 COVID-19 Vaccines and extensive family history of cancer.
In October 2025, he started:
Ivermectin 1mg/kg/day
Mebendazole 1000mg/day
Chemo
Results after 7 months: Cancer Free!
COMMENT:
This is such an illustrative case.
Here the Oncologist was giving advice that was detrimental to the cancer patient, but safe for the Oncologist. “Don’t take repurposed drugs with chemo”.
Thank God the patient did the opposite, combined Ivermectin and Mebendazole with chemo, and is now Cancer Free. 😃
This struggle happens all the time!
On one hand, you have a patient who has discovered repurposed drugs.
On the other hand, you have an Oncologist who is telling their patient NOT to take repurposed drugs (which have hundreds of published studies about ENHANCING and IMPROVING the effect of chemo).
Why would an Oncologist give terrible advice to their patient?
Oncologists face no consequence for giving you a bad treatment combinations or bad treatment advice. In fact, they get paid exactly the same.
It's the only medical specialty that rewards failure.
If this patient listened to their Oncologist, there is a non-zero probability that their chemo treatment would have failed and they would still have cancer.
That’s why it’s SO IMPORTANT to have another opinion available and this is why over 9000 Cancer patients from around the world have come to me.
This is also why they want to stop me so badly.
If cancer patients actually have options, Big Pharma’s tight control over Cancer Care would completely collapse.
We are talking a $200 billion a year industry that faces imminent collapse.
I have helped over 9000 Cancer patients with Ivermectin, Mebendazole and Fenbendazole in the largest Ivermectin Cancer project in the world.
This Ivermectin Cancer Project is now moving to FLORIDA! Cancer patients must have options.
Article link in first photo at the top to avoid shadowbanning on X (yes it still happens).
Just learnt of this session. Important issues facing patients with papillary disease bladder cancer and patients facing shortage of BCG. These are the issues I have been discussing with FDA for a long time and will address them at our AUA talk on Saturday. Will livestream and share the presentation thereafter. Stay tuned.
@MakisMedicine Brilliant move, Dr. Makis! Turning down the $400k Mayo golden handcuffs to build your own Florida clinic with ivermectin + mebendazole protocols is legendary. True independence > institutional capture. Patients win when doctors like you stay free. Go build it! 💪
🍅 Can what you eat influence your cancer risk?
Lycopene, the bioactive in tomatoes, may reduce inflammation, limit abnormal cell growth, and regulate blood vessel formation linked to tumor progression.
🗓️ Join me LIVE May 7· Link in bio
#CancerPrevention#FoodAsMedicine
@GreereMedeea Fact check
Real: Russia started personalized mRNA therapeutic vaccine (Neooncovac) for melanoma patients on Apr 1 2026; state-funded for eligible cases.
Exaggerated: No proven 80% tumor shrink in humans yet (preclinical); not a universal "free for all" cure. Early stage only.
Medical researcher Dr. Patrick Soon-Shiong has successfully spearheaded a revolutionary new cancer treatment. It has recently received official FDA approval in the United States and regulatory clearance in Saudi Arabia.
This advanced immunotherapy drug, known commercially as Anktiva, fundamentally shifts how modern medicine fights the disease. Instead of relying on toxic traditional chemotherapy, it supercharges the human immune system at a microscopic cellular level.
The therapy specifically activates and multiplies "Natural Killer" (NK) cells. These incredibly complex cellular structures act as the body's natural frontline defense. They are uniquely designed to physically identify, bind to, and destroy abnormal mutating cells without needing prior exposure.
By chemically boosting the targeted activity of these NK cells, the treatment allows the immune system to aggressively dismantle tumors on its own. It is a massive, highly targeted leap forward in biological cancer care.
@plarsenviking1@SmartScience Anktiva is FDA-approved only for BCG-unresponsive non-muscle invasive bladder cancer. It activates NK cells locally there—no approval or strong evidence yet for metastatic breast cancer or liver mets. There are suggestion of successful response in other cancers too.
The power of NK cells. Decoding sepsis with immunotherapy. Clinical trials open and more to come.
Addressing lymphopenia in sepsis. ALC matters.
https://t.co/XQ3mHxgWRQ
https://t.co/gARRiNYjlX
2025 was the unveiling of the Bioshield Platform - Anktiva as foundation for killer cells.
Now for 2026 unveil. Next element to Bioshield Platform - engineered NK cells to TARGET cancer. The CAR-NK in Phase 2 trials infused w/ Anktiva https://t.co/pq1J6d7LcY
See you at JPM26